EMA: Regulatory Decisions On Pediatric Cancer Drugs ‘Cannot Happen In Isolation’

Stakeholders must work together to “identify the most promising products based on evidence” to treat childhood cancers, as drugs developed for adults do not always work, the scientific officer for the pediatric medicines office at the European Medicines Agency says.